- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-09-0046724

Etico Research Private Limited
About Etico Research Private Limited
Data last updated:
Etico Research Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 31 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC120349. Its GSTIN is 36AAECE8329D1ZP (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Prathap Narendra and Sudhireddy Venkateshwara Reddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹32.77 Lakh. For the same year it recorded a net loss of ₹15.18 Lakh (net margin -46.3%) and EBITDA of -₹15.11 Lakh (EBITDA margin -46.1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 75% over five years.
Etico Research Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0046724). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Etico Research
Contact details
Etico Research Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 32 First Floor Sri Sai Chandra Residency, Pupalaguda Gandipet Mandal, Hyderabad, Telangana, India – 500089
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Etico Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Etico Research is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Etico Research Private Limited, buy the company report.
Financials of Etico Research Private Limited
FY 2025 filings availableEtico Research Private Limited reported revenue of ₹32.77 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 75% over five years. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹15.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹15.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -46.1% | ||||
| Net Profit Margin | -46.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Etico Research Private Limited, buy the company report.
Board of directors of Etico Research Private Limited
Etico Research has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prathap Narendra | Director | 01 Aug 2024 | 2 Years 3 Months | Current |
| Sudhireddy Venkateshwara Reddy | Director | 01 Aug 2024 | 2 Years 3 Months | Current |
| Venkata Praveen Chadarasipalli | Director | 01 Aug 2024 | 2 Years 3 Months | Current |
| Molugu Shiva Kumar | Director | 25 Jan 2025 | 1 Years 9 Months | Current |
Peer comparison
Etico Research Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Contract Research, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Charitra Pharmaceuticals Private Limited | ₹33.08 Lakh (FY 2023) | 25.0% | Hyderabad, Telangana, India | |||
| Ariseetios Pharmaceutical Private Limited | ₹32.86 Lakh (FY 2025) | -31.0% | Ranchi, Jharkhand, India | |||
| Noble Remedies(India)Pvt Ltd | ₹32.8 Lakh (FY 2024) | -1.0% | Haryana, India | |||
| Etico Research Private Limitedthis company | ₹32.77 Lakh (FY 2024) | -₹15.18 Lakh | -46.3% | Hyderabad, Telangana, India | ||
| Heilent Pharmaceuticals Private Limited | ₹32.7 Lakh (FY 2025) | -16.0% | Sulthan Bathery, Kerala, India | |||
| Aadmex Lifesciences Private Limited | ₹32.67 Lakh (FY 2025) | -22.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Etico Research Private Limited, buy the company report.
Auditor
Etico Research Private Limited is audited by PBJ and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PBJ and Associates | FY 2023 | 017752S |
Shareholding
The shareholding of Etico Research Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Etico Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Etico Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Etico Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Etico Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECE8329D1ZP | Telangana | Active | 11 Jan 2018 |
To see the full GST registrations and return filing status of Etico Research Private Limited, buy the company report.
Recent activity
Etico Research Private Limited has 10 board changes on record since 2018: 4 appointments and 6 cessations. The latest: Molugu Shiva Kumar was appointed as Director on 25 Jan 2025.
1 earlier event is in the company report.
Frequently asked questions
Etico Research is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 31 October 2017 (9+ years old) and is registered under CIN U74999TG2017PTC120349.
Etico Research has 4 current directors:
- Prathap Narendra - Director
- Sudhireddy Venkateshwara Reddy - Director
- Venkata Praveen Chadarasipalli - Director
- Molugu Shiva Kumar - Director
The latest financial statements of Etico Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Etico Research is 36AAECE8329D1ZP, registered in Telangana.
The CIN (Corporate Identification Number) of Etico Research is U74999TG2017PTC120349. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Etico Research was incorporated on 31 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Etico Research by revenue are Charitra Pharmaceuticals Private Limited, Ariseetios Pharmaceutical Private Limited, Noble Remedies(India)Pvt Ltd, Heilent Pharmaceuticals Private Limited, Aadmex Lifesciences Private Limited, all in the Pharma industry (Contract Research, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Molugu Shiva Kumar was appointed as Director on 25 Jan 2025. Sanjeev Goverdhan Angampally ceased to be Director on 23 Jan 2025. Gayatri Ram Kaza ceased to be Director on 05 Aug 2024. Etico Research has 10 board changes on record in total.
Yes, Etico Research is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0046724).
The registered office of Etico Research is at Plot No. 32 First Floor Sri Sai Chandra Residency, Pupalaguda Gandipet Mandal, Hyderabad, Telangana, India – 500089.
Etico Research operates in the pharma industry, in the pharma contract r and d segment.

